Zheng, Feiyang
Wang, Dan
Zhang, Xinping
Article History
Received: 15 May 2022
Accepted: 30 August 2022
First Online: 14 September 2022
Declarations
:
: This trial was approved by the ethics committee of The First Affiliated Hospital of Medical College of Xinjiang Shihezi University Hospital (kj2020–087-03) and registered in the China clinical trial registry (ExternalRef removed, number ChiCTR2000035321 date: 08/08/2020). Written informed consent were obtained from all subjects. For participants who couldn’t read the informed consent form (illiterate participant), the document was orally presented to them or their legally authorized representative, in the presence of an independent witness. The informed consent was approved by the ethics committee of The First Affiliated Hospital of Medical College of Xinjiang Shihezi University Hospital. All methods were performed in accordance with the relevant guidelines and regulations or in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.